Neonatal Jaundice: Causes, Phototherapy Thresholds & AAP 2022 Guidelines | RxMedCalc
A complete guide to jaundice in newborns — physiological vs pathological, bilirubin thresholds, when to start phototherapy, exchange transfusion, G6PD, and kernicterus prevention.
A yellow baby is one of the most common sights in any postnatal ward. Neonatal jaundice — medically called neonatal hyperbilirubinaemia — affects approximately 60% of term newborns and up to 80% of preterm infants in the first week of life. For most babies, it is a normal and self-limiting part of the transition from womb to world.
But bilirubin — the yellow pigment that causes the colour — is also a neurotoxin. At high enough levels it crosses the blood-brain barrier and damages the basal ganglia, auditory nuclei, and cerebellum, causing a devastating and preventable condition called kernicterus. Every case of kernicterus represents a failure of monitoring or treatment that should never have happened.
The 2022 AAP guidelines fundamentally changed how neonatal jaundice is managed — lowering treatment thresholds, mandating universal screening, and stratifying risk more precisely. This guide explains everything from the basic biology to the clinical decision-making framework.
Why Do Newborns Become Jaundiced?
The yellow colour comes from bilirubin — a breakdown product of haemoglobin. When red blood cells die, haemoglobin is broken down into haem, which is converted to bilirubin. In adults, the liver rapidly conjugates and excretes bilirubin into bile. In newborns, this system is temporarily overwhelmed for several reasons:
- Higher red cell turnover: Foetal haemoglobin (HbF) is replaced by adult haemoglobin (HbA) after birth, causing a surge in red cell breakdown
- Immature liver enzyme activity: The UGT1A1 enzyme that conjugates bilirubin is underexpressed in newborns, particularly preterm infants
- Enterohepatic recirculation: The newborn gut reabsorbs unconjugated bilirubin back into the bloodstream — breastfed babies are particularly affected as breast milk contains beta-glucuronidase which increases this recirculation
The result is a transient rise in unconjugated (indirect) bilirubin in the blood — unconjugated bilirubin is fat-soluble, crosses the blood-brain barrier, and is the form responsible for neurotoxicity.
Physiological vs. Pathological Jaundice
- Appears after 24 hours of life
- Peaks days 3–5 in term infants; days 5–7 in preterm
- Resolves by 1–2 weeks in term infants; by 3 weeks in preterm
- Bilirubin rise < 5 mg/dL per day
- Caused by normal neonatal physiology
- Treatment rarely needed unless threshold crossed
- Appears within first 24 hours — always pathological
- Bilirubin rise > 5 mg/dL per day
- Very high bilirubin crossing phototherapy threshold
- Prolonged: > 2 weeks in term; > 3 weeks in preterm
- Direct (conjugated) bilirubin elevated — always pathological
- Requires investigation and treatment
⚠️ Any jaundice appearing within the first 24 hours is pathological until proven otherwise. The most common cause is isoimmune haemolytic disease (ABO or Rh incompatibility). This is a neonatal emergency — do not wait to observe.
Causes of Pathological Neonatal Jaundice
| Cause | Mechanism | Key Clue |
|---|---|---|
| ABO incompatibility | Maternal anti-A or anti-B antibodies attack baby's red cells | Most common haemolytic cause. Mother O, baby A or B. Positive DAT. |
| Rh incompatibility | Maternal anti-D attacks Rh-positive baby's red cells | Rh-negative mother, Rh-positive baby. Prevented by anti-D prophylaxis. |
| G6PD deficiency | Oxidative stress → haemolysis | X-linked. Very common in Indian, African, Mediterranean populations. Can cause severe acute haemolysis. |
| Sepsis | Haemolysis + impaired hepatic conjugation | Unwell baby, temperature instability, raised CRP. |
| Hypothyroidism | Reduced hepatic UGT1A1 activity | Prolonged jaundice + poor feeding + constipation + hypotonia. Check TSH. |
| Breast milk jaundice | Beta-glucuronidase in breast milk increases enterohepatic recirculation | Healthy baby, well feeding, prolonged mild jaundice. Resolves spontaneously. |
| Biliary atresia | Conjugated (direct) hyperbilirubinaemia — bile duct obliteration | Pale/white stools, dark urine, progressive jaundice. Surgical emergency. Check direct bilirubin. |
G6PD Deficiency — A Special Concern in India
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme defect in the world, affecting approximately 7–10% of Indian males (X-linked condition). In neonates, G6PD deficiency can cause severe and rapidly rising jaundice — particularly when the baby is exposed to oxidative triggers: naphthalene (mothballs), certain medications (nitrofurantoin, dapsone, primaquine), henna, or infection.
The 2022 AAP guidelines recommend G6PD testing for all newborns in high-prevalence populations — which includes India. G6PD-deficient babies are classified as having a neurotoxicity risk factor, which lowers their phototherapy threshold.
AAP 2022 Phototherapy Thresholds
The 2022 AAP guidelines made landmark changes compared to the 2004 guidelines — most importantly, lowering phototherapy thresholds especially for late preterm infants (35–37 weeks) and any baby with neurotoxicity risk factors.
| Age (Hours) | ≥ 38 Wk, Low Risk (mg/dL) | 35–37 Wk or ANY Risk Factor (mg/dL) |
|---|---|---|
| 24 hours | 8.0 | 6.0 |
| 48 hours | 13.0 | 11.0 |
| 72 hours | 16.0 | 13.0 |
| 96 hours | 18.0 | 15.0 |
| ≥ 5 days | 18.0 | 15.0 |
Neurotoxicity risk factors that lower the threshold to the right-hand column:
- Isoimmune haemolytic disease (ABO/Rh incompatibility with positive direct antiglobulin test)
- G6PD deficiency (confirmed or suspected)
- Albumin < 3.0 g/dL
- Sepsis, clinical instability, or significant acidosis/hypoxia
⚠️ Exchange transfusion threshold is approximately 2 mg/dL above the phototherapy threshold at each time point. Exchange transfusion is a high-risk procedure but may be life-saving in severe hyperbilirubinaemia. Any baby approaching exchange threshold requires immediate escalation to a neonatal unit.
👶 Use the RxMedCalc Neonatal Jaundice Calculator — enter gestational age, age in hours, TSB, and neurotoxicity risk factors to get phototherapy and exchange transfusion thresholds per AAP 2022.
How Is Phototherapy Given?
Phototherapy works by converting unconjugated bilirubin in the skin into water-soluble isomers (primarily lumirubin) that can be excreted in bile and urine without hepatic conjugation. Blue-green light (wavelength 460–490 nm) is most effective.
- Intensive phototherapy: High-irradiance blue LED lights placed close to the baby (15–20 cm). Expose maximum skin surface area — remove nappy if possible, turn baby regularly.
- Eye protection: Always protect the baby's eyes with phototherapy goggles — light exposure can cause retinal damage.
- Hydration: Phototherapy increases insensible water losses. Ensure adequate feeding. Supplemental IV fluids may be needed in dehydrated babies.
- Temperature monitoring: Light sources generate heat — monitor temperature every 2–4 hours.
- TSB monitoring: Check bilirubin every 4–12 hours depending on initial level and rate of rise. Discontinue when bilirubin falls > 2 mg/dL below threshold and is trending down.
Kernicterus — The Preventable Catastrophe
Kernicterus is bilirubin-induced permanent neurological damage. It occurs when extremely high unconjugated bilirubin levels saturate albumin binding capacity and free bilirubin crosses the blood-brain barrier. It causes:
- Acute phase: Hypotonia → hypertonia, high-pitched cry, retrocollis/opisthotonos, seizures, coma
- Chronic phase (survivors): Athetoid cerebral palsy, sensorineural hearing loss (auditory neuropathy), dental enamel hypoplasia, upward gaze palsy
Kernicterus is entirely preventable with universal screening, timely phototherapy, and early recognition of risk factors. In India, it remains more common than in high-income countries due to late presentation, delayed initiation of phototherapy, and under-recognition of G6PD deficiency.
What Parents Should Watch For at Home
After early hospital discharge (which is increasingly common), parents must know the warning signs:
- Yellow colour spreading below the belly button or reaching the palms and soles — deepening jaundice
- Baby is very difficult to wake for feeds, excessively sleepy
- Baby is not feeding well or passing fewer than 6 wet nappies per day after day 4
- High-pitched cry — an early sign of bilirubin neurotoxicity
- Jaundice appearing before day 2 — always pathological
- Jaundice still present at more than 2 weeks of age
- Pale or white stools with dark urine — suggests conjugated jaundice / biliary problem
Key Takeaways
- Neonatal jaundice affects 60% of term and 80% of preterm babies — most is physiological
- Any jaundice in first 24 hours is pathological — investigate immediately
- AAP 2022 uses lower phototherapy thresholds, especially for late preterm and babies with neurotoxicity risk factors
- Neurotoxicity risk factors (G6PD, haemolysis, low albumin, sepsis) lower phototherapy threshold by ~2 mg/dL
- G6PD deficiency affects ~7–10% of Indian males — high-risk population; screen and protect from triggers
- Pale stools + dark urine = possible biliary atresia — surgical emergency, refer urgently
- Kernicterus is preventable — universal predischarge bilirubin screening catches at-risk babies before discharge
- Phototherapy: maximum skin exposure, eye protection, monitor temperature and TSB every 4–12 hours
References
- Kemper AR et al. Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation. Pediatrics. 2022;150(3):e2022058859.
- American Academy of Pediatrics. Neonatal Jaundice and Kernicterus — Clinical Report. Pediatrics. 2022.
- Indian Academy of Pediatrics (IAP). IAP Guidelines on Neonatal Jaundice Management. Indian Pediatrics. 2020.
- Bhutani VK et al. Predischarge jaundice nomogram for term and late preterm newborns. Pediatrics. 1999;103(1):6-14.
- WHO. Guidelines on Basic Newborn Resuscitation. Geneva: WHO Press, 2012.
This article is for educational purposes based on AAP 2022 and IAP guidelines. Phototherapy and exchange transfusion decisions must be made by qualified neonatal medical personnel using the full clinical nomogram and individual patient assessment.
Built by an MBBS, AFIH Certified Physician in Punjab, India | RxMedCalc.com